ID   DDX6_HUMAN              Reviewed;         483 AA.
AC   P26196; Q5D048;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   22-JUL-2015, entry version 166.
DE   RecName: Full=Probable ATP-dependent RNA helicase DDX6;
DE            EC=3.6.4.13;
DE   AltName: Full=ATP-dependent RNA helicase p54;
DE   AltName: Full=DEAD box protein 6;
DE   AltName: Full=Oncogene RCK;
GN   Name=DDX6; Synonyms=HLR2, RCK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1579499; DOI=10.1093/nar/20.8.1967;
RA   Lu D., Yunis J.J.;
RT   "Cloning, expression and localization of an RNA helicase gene from a
RT   human lymphoid cell line with chromosomal breakpoint 11q23.3.";
RL   Nucleic Acids Res. 20:1967-1972(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12-483.
RC   TISSUE=Lung;
RX   PubMed=1394235;
RA   Akao Y., Seto M., Yamamoto K., Iida S., Nakazawa S., Inazawa J.,
RA   Abe T., Takahashi T., Ueda R.;
RT   "The RCK gene associated with t(11;14) translocation is distinct from
RT   the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations.";
RL   Cancer Res. 52:6083-6087(1992).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH DCP1A; DCP2;
RP   EDC3 AND EDC4, AND SUBCELLULAR LOCATION.
RX   PubMed=16364915; DOI=10.1016/j.molcel.2005.10.031;
RA   Fenger-Groen M., Fillman C., Norrild B., Lykke-Andersen J.;
RT   "Multiple processing body factors and the ARE binding protein TTP
RT   activate mRNA decapping.";
RL   Mol. Cell 20:905-915(2005).
RN   [5]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH APOBEC3G.
RX   PubMed=16699599; DOI=10.1371/journal.ppat.0020041;
RA   Wichroski M.J., Robb G.B., Rana T.M.;
RT   "Human retroviral host restriction factors APOBEC3G and APOBEC3F
RT   localize to mRNA processing bodies.";
RL   PLoS Pathog. 2:E41-E41(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-36, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH LIMD1; WTIP AND AJUBA.
RX   PubMed=20616046; DOI=10.1073/pnas.0914987107;
RA   James V., Zhang Y., Foxler D.E., de Moor C.H., Kong Y.W., Webb T.M.,
RA   Self T.J., Feng Y., Lagos D., Chu C.Y., Rana T.M., Morley S.J.,
RA   Longmore G.D., Bushell M., Sharp T.V.;
RT   "LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for
RT   microRNA-mediated gene silencing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:12499-12504(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22915799; DOI=10.1128/JVI.00595-12;
RA   Phalora P.K., Sherer N.M., Wolinsky S.M., Swanson C.M., Malim M.H.;
RT   "HIV-1 replication and APOBEC3 antiviral activity are not regulated by
RT   P bodies.";
RL   J. Virol. 86:11712-11724(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 94-299.
RX   PubMed=14684915;
RA   Matsui T., Hogetsu K., Akao Y., Tanaka M., Sato T., Kumasaka T.,
RA   Tanaka N.;
RT   "Crystallization and X-ray analysis of the N-terminal core domain of a
RT   tumour-associated human DEAD-box RNA helicase, rck/p54.";
RL   Acta Crystallogr. D 60:156-159(2004).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 296-483 IN COMPLEX WITH EDC3,
RP   MUTAGENESIS OF GLN-320; HIS-323; THR-327 AND ARG-331, AND INTERACTION
RP   WITH EDC3.
RX   PubMed=19285948; DOI=10.1016/j.molcel.2009.02.014;
RA   Tritschler F., Braun J.E., Eulalio A., Truffault V., Izaurralde E.,
RA   Weichenrieder O.;
RT   "Structural basis for the mutually exclusive anchoring of P body
RT   components EDC3 and Tral to the DEAD box protein DDX6/Me31B.";
RL   Mol. Cell 33:661-668(2009).
CC   -!- FUNCTION: In the process of mRNA degradation, may play a role in
CC       mRNA decapping.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC   -!- SUBUNIT: Forms a complex with DCP1A, DCP2, EDC3 and EDC4/HEDLS.
CC       Interacts with LIMD1, WTIP and AJUBA. Interacts with APOBEC3G in
CC       an RNA-dependent manner. Interacts with RC3H1 (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q08117:AES; NbExp=3; IntAct=EBI-351257, EBI-717810;
CC       Q99700:ATXN2; NbExp=7; IntAct=EBI-351257, EBI-697691;
CC       Q8N7W2-2:BEND7; NbExp=3; IntAct=EBI-351257, EBI-10181188;
CC       Q96CA5:BIRC7; NbExp=3; IntAct=EBI-351257, EBI-517623;
CC       Q13137:CALCOCO2; NbExp=3; IntAct=EBI-351257, EBI-739580;
CC       Q8NHQ1:CEP70; NbExp=3; IntAct=EBI-351257, EBI-739624;
CC       Q9NPI6:DCP1A; NbExp=5; IntAct=EBI-351257, EBI-374238;
CC       Q96F86:EDC3; NbExp=5; IntAct=EBI-351257, EBI-997311;
CC       Q9NRA8:EIF4ENIF1; NbExp=3; IntAct=EBI-351257, EBI-301024;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-351257, EBI-618309;
CC       Q13422:IKZF1; NbExp=3; IntAct=EBI-351257, EBI-745305;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-351257, EBI-10171697;
CC       P60410:KRTAP10-8; NbExp=3; IntAct=EBI-351257, EBI-10171774;
CC       Q15233-2:NONO; NbExp=3; IntAct=EBI-351257, EBI-10203843;
CC       Q96PV4:PNMA5; NbExp=3; IntAct=EBI-351257, EBI-10171633;
CC       Q59EK9:RUNDC3A; NbExp=3; IntAct=EBI-351257, EBI-747225;
CC       Q96C92-2:SDCCAG3; NbExp=3; IntAct=EBI-351257, EBI-10178036;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-351257, EBI-533224;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-351257, EBI-719493;
CC       O94972:TRIM37; NbExp=3; IntAct=EBI-351257, EBI-741602;
CC       Q8N1B4:VPS52; NbExp=3; IntAct=EBI-351257, EBI-2799833;
CC       Q96BR9:ZBTB8A; NbExp=3; IntAct=EBI-351257, EBI-742740;
CC       P17028:ZNF24; NbExp=3; IntAct=EBI-351257, EBI-707773;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body
CC       {ECO:0000269|PubMed:16364915, ECO:0000269|PubMed:16699599,
CC       ECO:0000269|PubMed:20616046, ECO:0000269|PubMed:22915799}.
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in most tissues.
CC   -!- DISEASE: Note=A chromosomal aberration involving DDX6 may be a
CC       cause of hematopoietic tumors such as B-cell lymphomas.
CC       Translocation t(11;14)(q23;q32).
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. DDX6/DHH1
CC       subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 helicase ATP-binding domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00541}.
CC   -!- SIMILARITY: Contains 1 helicase C-terminal domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00542}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z11685; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC065007; AAH65007.1; -; mRNA.
DR   EMBL; D17532; BAA04482.1; -; mRNA.
DR   CCDS; CCDS44751.1; -.
DR   PIR; S22651; S22651.
DR   RefSeq; NP_001244120.1; NM_001257191.2.
DR   RefSeq; NP_004388.2; NM_004397.5.
DR   RefSeq; XP_005271474.1; XM_005271417.2.
DR   UniGene; Hs.408461; -.
DR   PDB; 1VEC; X-ray; 2.01 A; A/B=94-299.
DR   PDB; 2WAX; X-ray; 2.30 A; A/C=296-483.
DR   PDB; 2WAY; X-ray; 2.30 A; A/C=296-483.
DR   PDB; 4CRW; X-ray; 1.75 A; B=307-483.
DR   PDB; 4CT4; X-ray; 2.30 A; B/D=95-469.
DR   PDB; 4CT5; X-ray; 3.00 A; A/B=95-469.
DR   PDBsum; 1VEC; -.
DR   PDBsum; 2WAX; -.
DR   PDBsum; 2WAY; -.
DR   PDBsum; 4CRW; -.
DR   PDBsum; 4CT4; -.
DR   PDBsum; 4CT5; -.
DR   ProteinModelPortal; P26196; -.
DR   SMR; P26196; 63-469.
DR   BioGrid; 108022; 67.
DR   DIP; DIP-29195N; -.
DR   IntAct; P26196; 55.
DR   MINT; MINT-5004149; -.
DR   STRING; 9606.ENSP00000264018; -.
DR   PhosphoSite; P26196; -.
DR   BioMuta; DDX6; -.
DR   DMDM; 116241327; -.
DR   DOSAC-COBS-2DPAGE; P26196; -.
DR   MaxQB; P26196; -.
DR   PaxDb; P26196; -.
DR   PeptideAtlas; P26196; -.
DR   PRIDE; P26196; -.
DR   DNASU; 1656; -.
DR   Ensembl; ENST00000526070; ENSP00000433704; ENSG00000110367.
DR   Ensembl; ENST00000534980; ENSP00000442266; ENSG00000110367.
DR   Ensembl; ENST00000620157; ENSP00000478754; ENSG00000110367.
DR   GeneID; 1656; -.
DR   KEGG; hsa:1656; -.
DR   UCSC; uc001pub.2; human.
DR   CTD; 1656; -.
DR   GeneCards; GC11M118619; -.
DR   HGNC; HGNC:2747; DDX6.
DR   HPA; CAB004668; -.
DR   HPA; HPA024201; -.
DR   HPA; HPA026644; -.
DR   MIM; 600326; gene.
DR   neXtProt; NX_P26196; -.
DR   PharmGKB; PA27229; -.
DR   eggNOG; COG0513; -.
DR   GeneTree; ENSGT00800000124155; -.
DR   HOGENOM; HOG000268797; -.
DR   HOVERGEN; HBG106685; -.
DR   InParanoid; P26196; -.
DR   KO; K12614; -.
DR   OMA; KNFMEKH; -.
DR   OrthoDB; EOG7D85W7; -.
DR   PhylomeDB; P26196; -.
DR   TreeFam; TF300440; -.
DR   BRENDA; 3.6.4.13; 2681.
DR   Reactome; REACT_20518; mRNA decay by 5' to 3' exoribonuclease.
DR   ChiTaRS; DDX6; human.
DR   EvolutionaryTrace; P26196; -.
DR   GeneWiki; DDX6; -.
DR   GenomeRNAi; 1656; -.
DR   NextBio; 6820; -.
DR   PRO; PR:P26196; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; P26196; -.
DR   CleanEx; HS_DDX6; -.
DR   ExpressionAtlas; P26196; baseline and differential.
DR   Genevisible; P26196; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0000932; C:cytoplasmic mRNA processing body; IDA:UniProtKB.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0016442; C:RISC complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004004; F:ATP-dependent RNA helicase activity; IBA:GO_Central.
DR   GO; GO:0004386; F:helicase activity; TAS:ProtInc.
DR   GO; GO:0044822; F:poly(A) RNA binding; IDA:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:BHF-UCL.
DR   GO; GO:0003724; F:RNA helicase activity; TAS:ProtInc.
DR   GO; GO:0033962; P:cytoplasmic mRNA processing body assembly; IDA:MGI.
DR   GO; GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome.
DR   GO; GO:0006417; P:regulation of translation; IBA:GO_Central.
DR   GO; GO:0010501; P:RNA secondary structure unwinding; IBA:GO_Central.
DR   GO; GO:0019827; P:stem cell maintenance; IEA:Ensembl.
DR   GO; GO:0019074; P:viral RNA genome packaging; IMP:CACAO.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000629; RNA-helicase_DEAD-box_CS.
DR   InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00039; DEAD_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51195; Q_MOTIF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Chromosomal rearrangement;
KW   Complete proteome; Cytoplasm; Helicase; Hydrolase; Nucleotide-binding;
KW   Phosphoprotein; Proto-oncogene; Reference proteome; RNA-binding.
FT   CHAIN         1    483       Probable ATP-dependent RNA helicase DDX6.
FT                                /FTId=PRO_0000054983.
FT   DOMAIN      127    298       Helicase ATP-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN      308    468       Helicase C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00542}.
FT   NP_BIND     140    147       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00541}.
FT   MOTIF        96    124       Q motif.
FT   MOTIF       246    249       DEAD box.
FT   MOD_RES      36     36       Phosphothreonine.
FT                                {ECO:0000269|PubMed:17525332}.
FT   MUTAGEN     320    320       Q->A: Abolishes interaction with EDC3;
FT                                when associated with A-323; A-327 and A-
FT                                331. {ECO:0000269|PubMed:19285948}.
FT   MUTAGEN     323    323       H->A: Abolishes interaction with EDC3;
FT                                when associated with A-320; A-327 and A-
FT                                331. {ECO:0000269|PubMed:19285948}.
FT   MUTAGEN     327    327       T->A: Abolishes interaction with EDC3;
FT                                when associated with A-320; A-323 and A-
FT                                331. {ECO:0000269|PubMed:19285948}.
FT   MUTAGEN     331    331       R->A: Abolishes interaction with EDC3;
FT                                when associated with A-320; A-323 and A-
FT                                327. {ECO:0000269|PubMed:19285948}.
FT   CONFLICT    293    293       Q -> E (in Ref. 1; Z11685).
FT                                {ECO:0000305}.
FT   HELIX        98    100       {ECO:0000244|PDB:1VEC}.
FT   HELIX       105    112       {ECO:0000244|PDB:1VEC}.
FT   TURN        113    115       {ECO:0000244|PDB:1VEC}.
FT   HELIX       121    131       {ECO:0000244|PDB:1VEC}.
FT   STRAND      136    139       {ECO:0000244|PDB:1VEC}.
FT   STRAND      142    144       {ECO:0000244|PDB:1VEC}.
FT   HELIX       147    157       {ECO:0000244|PDB:1VEC}.
FT   STRAND      167    170       {ECO:0000244|PDB:1VEC}.
FT   HELIX       174    187       {ECO:0000244|PDB:1VEC}.
FT   TURN        188    190       {ECO:0000244|PDB:1VEC}.
FT   STRAND      191    193       {ECO:0000244|PDB:1VEC}.
FT   STRAND      196    199       {ECO:0000244|PDB:1VEC}.
FT   STRAND      201    203       {ECO:0000244|PDB:1VEC}.
FT   HELIX       205    211       {ECO:0000244|PDB:1VEC}.
FT   STRAND      217    221       {ECO:0000244|PDB:1VEC}.
FT   HELIX       223    231       {ECO:0000244|PDB:1VEC}.
FT   STRAND      242    247       {ECO:0000244|PDB:1VEC}.
FT   HELIX       248    251       {ECO:0000244|PDB:1VEC}.
FT   TURN        254    256       {ECO:0000244|PDB:1VEC}.
FT   HELIX       257    266       {ECO:0000244|PDB:1VEC}.
FT   STRAND      272    278       {ECO:0000244|PDB:1VEC}.
FT   HELIX       282    291       {ECO:0000244|PDB:1VEC}.
FT   STRAND      296    298       {ECO:0000244|PDB:1VEC}.
FT   STRAND      309    315       {ECO:0000244|PDB:4CRW}.
FT   HELIX       318    320       {ECO:0000244|PDB:4CRW}.
FT   HELIX       321    331       {ECO:0000244|PDB:4CRW}.
FT   STRAND      335    340       {ECO:0000244|PDB:4CRW}.
FT   HELIX       344    356       {ECO:0000244|PDB:4CRW}.
FT   STRAND      361    364       {ECO:0000244|PDB:4CRW}.
FT   STRAND      366    368       {ECO:0000244|PDB:4CRW}.
FT   HELIX       370    381       {ECO:0000244|PDB:4CRW}.
FT   STRAND      384    390       {ECO:0000244|PDB:4CRW}.
FT   HELIX       397    399       {ECO:0000244|PDB:4CT4}.
FT   STRAND      403    410       {ECO:0000244|PDB:4CRW}.
FT   HELIX       415    422       {ECO:0000244|PDB:4CRW}.
FT   HELIX       423    425       {ECO:0000244|PDB:4CRW}.
FT   STRAND      432    438       {ECO:0000244|PDB:4CRW}.
FT   HELIX       440    442       {ECO:0000244|PDB:4CRW}.
FT   HELIX       443    453       {ECO:0000244|PDB:4CRW}.
FT   HELIX       462    465       {ECO:0000244|PDB:4CT4}.
FT   HELIX       466    468       {ECO:0000244|PDB:2WAX}.
SQ   SEQUENCE   483 AA;  54417 MW;  F802C642861793FB CRC64;
     MSTARTENPV IMGLSSQNGQ LRGPVKPTGG PGGGGTQTQQ QMNQLKNTNT INNGTQQQAQ
     SMTTTIKPGD DWKKTLKLPP KDLRIKTSDV TSTKGNEFED YCLKRELLMG IFEMGWEKPS
     PIQEESIPIA LSGRDILARA KNGTGKSGAY LIPLLERLDL KKDNIQAMVI VPTRELALQV
     SQICIQVSKH MGGAKVMATT GGTNLRDDIM RLDDTVHVVI ATPGRILDLI KKGVAKVDHV
     QMIVLDEADK LLSQDFVQIM EDIILTLPKN RQILLYSATF PLSVQKFMNS HLQKPYEINL
     MEELTLKGVT QYYAYVTERQ KVHCLNTLFS RLQINQSIIF CNSSQRVELL AKKISQLGYS
     CFYIHAKMRQ EHRNRVFHDF RNGLCRNLVC TDLFTRGIDI QAVNVVINFD FPKLAETYLH
     RIGRSGRFGH LGLAINLITY DDRFNLKSIE EQLGTEIKPI PSNIDKSLYV AEYHSEPVED
     EKP
//
